Form 8-K - Current report:
SEC Accession No. 0001193125-26-292567
Filing Date
2026-07-01
Accepted
2026-07-01 16:15:31
Documents
11
Period of Report
2026-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d61061d8k.htm   iXBRL 8-K 27094
  Complete submission text file 0001193125-26-292567.txt   146196

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clym-20260629.xsd EX-101.SCH 3168
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20260629_lab.xml EX-101.LAB 18735
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20260629_pre.xml EX-101.PRE 11699
14 EXTRACTED XBRL INSTANCE DOCUMENT d61061d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 261145311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)